Research

The COVID 19 pandemic has affected people with neurological disease and reduced the care provided, with possible adverse sequelae, including frailty.

A new study has shown that a short-term palliative care intervention was seen positively by the patients and families and reduced costs, but did not alter symptom burden.

A plea for equitable global access to COVID‐19 diagnostics, vaccination and therapy: the NeuroCOVID‐19 task Force of the european Academy of neurology

The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioning

Stroke acute management and outcomes during the COVID-19 outbreak: A cohort study from the Madrid stroke network

Clinical, cerebrospinal fluid, and neuroimaging findings in COVID-19 encephalopathy: a case series

Stroke management during the COVID-19 outbreak: challenges and results of a hub-center in Lombardy, Italy

Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?

Neurological infection with SARS-CoV-2 - the story so far

Neurological features and outcome in COVID-19: dementia can predict severe disease

Headache during SARS-CoV-2 infection as an early symptom associated with a more benign course of disease: a case-control study

COVID-19: Neuroimaging features of a pandemic

Cerebral venous thrombosis and SARS-CoV-2 infection: a systematic review and meta-analysis

COVID-19 in teriflunomide-treated patients with multiple sclerosis: A case report and literature review

Sleep apnoea is a risk factor for severe COVID-19